| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Senior VP And General Counsel
3 companies
Harrington Michael J is a Director at ELAN, with reported holdings spanning 3 companies. Recent filings cover 8 purchases and 2 sales. Those positions are worth an estimated $78.6M at current prices.
Our model assigns Harrington Michael J a below-average insider score of 34/100, based on 5 past trades. Over a 12-month horizon, 20.0% of those trades were profitable, with an average 12-month return of -35.3%.
Harrington Michael J's largest disclosed position is in LLY as Senior VP And General Counsel, worth about $75.8M. The recent filings there lean toward selling, a net 38,833 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | ELAN Elanco Animal Health Incorporated | Director | Buy | 5,000 | $21.82 | $109,100.00 | +4.0% | - | - | |
| Dec 6, 2024 | NOTV Inotiv, Inc. | Director | Buy | 10,000 | $3.98 | $39,822.00 | +36.4% | -30.0% | -78.7% | |
| Aug 22, 2024 | ELAN Elanco Animal Health Inc | Director | Buy | 3,500 | $14.85 | $51,974.30 | +4.5% | -8.0% | +22.6% | |
| Mar 8, 2024 | ELAN Elanco Animal Health Inc | Director | Buy | 3,100 | $16.29 | $50,493.73 | +4.2% | +11.1% | -32.3% | |
| Nov 30, 2021 | ELAN Elanco Animal Health Inc | Director | Buy | 2,500 | $29.25 | $73,122.50 | +9.7% | -1.1% | -55.2% | |
| Aug 11, 2021 | ELAN Elanco Animal Health Inc | Director | Buy | 3,000 | $28.99 | $86,955.00 | +13.2% | +13.4% | -33.0% | |
| Mar 9, 2020 | ELAN Elanco Animal Health Inc | Director | Buy | 4,000 | $23.84 | $95,360.00 | +31.3% | - | - | |
| Jun 3, 2019 | LLY Eli Lilly & Co | Senior VP And General Counsel | Sell | 16,000 | $116.72 | $1,867,520.00 | -12.7% | - | - | |
| Apr 22, 2019 | ELAN Elanco Animal Health Inc | Director | Buy | 3,500 | $26.75 | $93,607.50 | +125.8% | - | - | |
| Jun 9, 2017 | LLY Eli Lilly & Co | Senior VP And General Counsel | Sell | 22,833 | $79.97 | $1,825,955.01 | -26.9% | - | - |